Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NuVasive, Inc. NUVA
$41.13
-$0.72 (-1.74%)
На 18:00, 12 мая 2023
+41.02%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
2181091920.00000000
-
week52high
58.55
-
week52low
35.17
-
Revenue
1201942000
-
P/E TTM
55
-
Beta
1.06678200
-
EPS
0.74000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 авг 2023 г. в 10:59
Описание компании
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Piper Sandler | Overweight | Overweight | 04 авг 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 15 июл 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 06 мая 2022 г. |
Wells Fargo | Overweight | Overweight | 05 мая 2022 г. |
Needham | Buy | Buy | 05 мая 2022 г. |
Truist Securities | Buy | Buy | 07 окт 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 07 окт 2022 г. |
Baird | Neutral | Neutral | 07 окт 2022 г. |
Needham | Buy | Buy | 30 сент 2022 г. |
Barclays | Overweight | 18 окт 2022 г. | |
Jefferies | Hold | 12 окт 2022 г. | |
Wells Fargo | Overweight | Overweight | 10 ноя 2022 г. |
RBC Capital | Outperform | Outperform | 10 ноя 2022 г. |
Piper Sandler | Overweight | Overweight | 10 ноя 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 10 ноя 2022 г. |
Needham | Hold | Buy | 06 янв 2023 г. |
Truist Securities | Buy | Buy | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Harbaugh Matthew K | D | 0 | 1286 | 01 янв 2023 г. |
Harbaugh Matthew K | D | 1858 | 440 | 01 янв 2023 г. |
Harbaugh Matthew K | A | 2298 | 1286 | 01 янв 2023 г. |
Norwalk Leslie V | D | 0 | 1547 | 01 июн 2022 г. |
Norwalk Leslie V | A | 3095 | 1547 | 01 июн 2022 г. |
Kadia Siddhartha | D | 0 | 2702 | 28 мая 2022 г. |
Kadia Siddhartha | A | 3739 | 3739 | 28 мая 2022 г. |
Wolterman Dan | A | 3788 | 3788 | 11 мая 2022 г. |
Rosenberg Donald J | D | 0 | 2702 | 11 мая 2022 г. |
Rosenberg Donald J | A | 22519 | 13326 | 11 мая 2022 г. |
Новостная лента
NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall
Zacks Investment Research
11 мая 2023 г. в 12:57
NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript
Seeking Alpha
10 мая 2023 г. в 22:15
NuVasive, Inc. (NASDAQ:NUVA ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Chris Barry - Chief Executive Officer Matt Harbaugh - Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Miksic - Barclays Bank Vikramjeet Chopra - Wells Fargo Securities Allen Gong - JP Morgan Joshua Jennings - Cowan Shagun Chadha - RBC David Saxon - Needham Matt Taylor - Jefferies Matthew Blackman - Stifel Operator Good day, ladies and gentlemen, and welcome to the NuVasive First Quarter 2023 Earnings Conference Call. I would now like to introduce your host for today's call, Ms.
NuVasive (NUVA) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research
10 мая 2023 г. в 18:59
NuVasive (NUVA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.54 per share a year ago.
Globus Medical: Still Very Attractive After NuVasive Selloff
Seeking Alpha
04 мая 2023 г. в 05:41
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst may be now priced in.
Is NuVasive (NUVA) a Great Value Stock Right Now?
Zacks Investment Research
01 мая 2023 г. в 11:25
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.